Search
for
Sort by
Research 211–240 of 1000+
- Uncovering novel biomarkers and drug targets for androgenetic alopecia via metabolite regulation and multi-tissue validation
- Development of Ethosomes for the Topical Treatment of Androgenic Alopecia: Ethanol Effect on Dutasteride Targeting to the Hair Follicles
- Data Sheet 1_SHP099-containing multi-targeting hydrogel promotes rapid skin reconstruction through modulating a variety of cells.zip
- SHP099-containing multi-targeting hydrogel promotes rapid skin reconstruction through modulating a variety of cells
- DNMT1 targets SRD5A2 to induce mitochondrial homeostasis and EMT in urothelial cells of hypospadias
- An update on nanocarriers for follicular-targeted drug delivery for androgenetic alopecia topical treatment
- 523 Targeting NETosis to treat delayed wound healing in a humanized mouse model of sickle cell disease
- 570 Targeting phosphodiesterase 8A (PDE8A) to boost adipogenesis and hair regeneration
- Wnt target gene Ascl4 is dispensable for skin appendage development
- Multi Targeted Non Invasive Photoceutical Therapeutic Approach for Combat and Traumatic Soft Tissue Injuries
- 129 Targeted inhibition of EGFR reduces anti-microbial defense mechanisms at the hair canal
- 176 Hair eruption initiates adverse events of EGFR-targeted cancer therapy
- Follicle-Targeted Delivery of Betamethasone and Minoxidil Co-Entrapped in Polymeric and Lipid Nanoparticles for Topical Alopecia Areata Treatment
- New Target for Minoxidil in the Treatment of Androgenetic Alopecia
- Acne tarda: paplitimas, endokrininis ryšys, terapinės priemonės.
- EPH39 Alopecia Areata: Targeted Review of Adverse Events Associated with Clinical Studies of Treatments
- 1113 Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils via Ly6 antigen for psoriasiform dermatitis alleviation
- Elevated Mammalian Target of Rapamycin (mTOR) Gene Expression in Acne Vulgaris patients
- A review on follicular targeting for the treatment of hirsutism
- 570 Targeting JAK/STAT and Wnt/b-catenin pathways and 5a-reductase activity to develop an effective anti-hair loss product
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- 026 Targeting pathogenic MICA-NKG2D interactions by statins: A novel adjunct treatment strategy for alopecia areata management?
- 415 Targeting inflammation and specialized pro-resolving mediators to reinforce barrier function and scalp homeostasis.
- Association of Acne Tarda with Endocrinological Disorders
- SKIN TARGETING OF AN OPTIMIZED CAFFEINE NANOSTRUCTURED LIPID CARRIER WITH IMPROVED EFFICIENCY AGAINST CHEMOTHERAPY INDUCED ALOPECIA
- Skin Targeting of An Optimized Caffeine Nanostructured Lipid Carrier With Improved Efficiency Against Chemotherapy Induced Alopecia
- Characterization of Soluplus/ASC-DP Nanoparticles Encapsulated with Minoxidil for Skin Targeting
- L-(+)-Tartaric Acid Minimally Affects the Viability or Molecular Signature but Increase the Expression of Selected Hair Growth Associated Genes in Human Dermal Papilla Cells
- 612 Targeted hair follicle delivery of hydrophilic molecules
- ORAL TARGETED THERAPY-INDUCED CUTANEOUS TOXICITY: LIFE EXPERIENCE OF PATIENTS WITH ADVANCED LUNG CANCER IN TAIWAN